Sector
1090 stories · page 35 of 55
“Today's announcement is the first of what we intend to be a series of growth developments and acquisitions to our clinical network,” Braxia Scientific CEO Roger McIntyre said
Zimaro brings over 20 years of public and private company experience in a wide range of finance functions, in particular specializing in high-growth environments, within various industries including psychedelics, the company said
The jab, which would also protect against the first Wuhan strain, may only need to be distributed once a year
“Future draft guidance documents from the Agency on NDIs are critical to the probiotic industry and many of our KGK Science clients,” Wellbeing Digital Sciences CEO Najla Guthrie said
The company said 93% of patients were retained to the primary endpoint and there have been no serious adverse events and suicide attempts to date
Irwin Naturals’ CFO Philippe Faraut said: “Profitability remained strong with an 11.2% operating margin despite start-up expenses related to building our cannabis licensing and psychedelic clinics businesses"
The loan will be used for working capital purposes as the company seeks additional sources of funding
“With this agreement, the third in one month, we will now have our THC augmented products in states with 2021 cannabis sales of around $8.7 billion,” the company's CEO Klee Irwin said
"Our roll-up strategy of clinics is highly accretive, enabling us to fuel rapid growth of revenues and profitability," the company's CEO, Klee Irwin said
"During the first quarter, the company concentrated on streamlining its operations to effectively manage resources,” CEO Ken Yoon said
The company said the approval was granted under the recently amended Health Canada Special Access Program, which was updated on January 5, 2022, to include access to psychedelic compounds on a case-by-case basis outside psychedelic trials
"Larsen Group II LLC was selected because of their growth-focused mindset and operational excellence. Importantly, they have one of the broadest distribution bases in the state - a state with $2.2 billion in cannabis sales last year,” said
"Adding another EBITDA positive ketamine clinic to our expanding footprint positions us well for accelerated growth of profitability,” CEO Klee Irwin said
"With this new partnership in a second state, we are executing towards our objective of having Irwin Naturals branded THC products on dispensary shelves in most of the country's 38 legal states,” Irwin CEO Klee Irwin said
"Women in this industry have so much to offer, and I am optimistic that WIP will foster an open, educational and collaborative atmosphere for women all around the world in which to share and create,” said the company’s CEO Najla Guthrie
"These record-breaking top and bottom-line numbers are fueling our accretive rollup of psychedelic mental health clinics featuring psychedelic treatment with ketamine," said Klee Irwin, president and CEO of the company
“We are excited to welcome Dr Ho to the MindScape facility and to Wellbeing overall, especially based on his impressive set of qualifications,” said Najla Guthrie, CEO of Wellbeing
“We are pleased that IRP Health continues to make strides toward improving the lives of veterans and first responders through the reactivation program,” said Wellbeing CEO Najla Guthrie
The integrated healthcare company said it also generated fourth-quarter revenue of C$2.7 million, as its gross margins improved to 55.6% from 53.1% during 3Q
“Our goal has always been to enrich peoples’ lives through mental health services and I am keen to see how the special committee can discover revolutionary, comprehensive and collaborative healthcare opportunities,” said Wellbeing CEO Najla
